#United States #New York #Levi Korsinsky #Applied Therapeutics #APLT

Investors Alert: Lead Plaintiff Deadline for APLT Securities Fraud Lawsuit

Levi & Korsinsky, LLP is reaching out to potential investors in Applied Therapeutics, Inc. regarding significant developments in a class action securities lawsuit. This legal action is particularly relevant for those adversely affected by alleged securities fraud that occurred between January 3, 2024, and December 2, 2024.

Case Background

The situation escalated on November 27, 2024, when Applied Therapeutics announced it had received a Complete Response Letter (CRL) from the FDA concerning its New Drug Application (NDA) for the company's lead drug candidate, govorestat. The CRL indicated that the FDA was unable to approve the NDA due to deficiencies in the clinical application. Responding to this news, Applied Therapeutics’ stock suffered a dramatic decline — plummeting from a closing price of $10.21 on November 26, 2024, to just $8.57 the next day. Further turmoil followed as shares fell to $2.03 by November 29, 2024, and dropped to $1.75 per share by December 2, 2024, marking a total decline of over 80%.

Serious Implications

The additional disclosure of a ‘warning letter’ from the FDA on December 2, 2024, referring to critical issues in clinical trials, further exacerbated the situation, causing the stock to tumble down to $1.29 per share by December 5, 2024. This swift decline has left many shareholders reeling and seeking information on their rights and possible compensation.

Important Deadline

Investors who suffered losses within this timeline now face an important deadline: February 18, 2025. This date is critical, as shareholders must request to be appointed as lead plaintiffs by this date to potentially take part in any compensatory measures. However, it’s also important to note that participating in the lawsuit does not require serving as a lead plaintiff.

No Cost to Participants

Levi & Korsinsky assures class members that there are no out-of-pocket costs or obligations to participate in the suit. If you are a class member impacted by the fraudulent activities, you could be eligible for compensation at no cost.

Why Choose Levi & Korsinsky?

Levi & Korsinsky has a strong track record over the past two decades, having recovered hundreds of millions of dollars for aggrieved shareholders. With expertise in handling complex securities litigation, the firm boasts over 70 dedicated professionals ready to assist clients. It has consistently ranked among the top securities litigation firms in the United States, according to ISS Securities Class Action Services.

How to Get Involved

If you are an investor in Applied Therapeutics, don’t hesitate to reach out to Joseph E. Levi at email protected] or call (212) 363-7500 to learn more about your options and rights. You can also visit [Levi & Korsinsky’s website for more details. Stay informed and don’t miss out on your legal rights as a shareholder.

As communities continue to monitor this unfolding situation, be sure to follow updates regarding the APLT lawsuit and the potential impact it may have on investors. Ensure you act before the lead plaintiff deadline to secure your rights and explore the possibilities of restitution.